Journal of Antimicrobial Chemotherapy · 2007 · 154 citations · 28 references
Life SciencesGeneticsMicrobiologyGene ExpressionMicrobial GeneticsTranscriptionBacterial Gene RegulationGene Expression RegulationTranscription FactorsTranscription In ProkaryotesTranscriptional ControlTranscriptional Regulation In ProkaryotesEfflux Pump Gene RegulationEfflux Pump GenesEfflux Pump MutationsEfflux Pump OverexpressionEscherichia ColiFrameshift MutationsMarr Family RegulatorsTransposon Mutagenesis
OBJECTIVES: The purpose of this study was to characterize decreased susceptibility to tigecycline in clinical isolates of Escherichia coli obtained during Phase 3 clinical trials. METHODS: Gene expression was analysed by transcriptional profile analysis and RT-PCR. Transposon mutagenesis with IS903kan was used for selection of transposon mutants. Transposon insertions were mapped by DNA sequencing and PCR analyses. The MICs were determined by broth microdilution. RESULTS: Both transcriptional profile analysis and Taqman RT-PCR demonstrated increased expression levels of MarA, a transcriptional activator, and AcrAB, an RND-type efflux pump, in the strains with elevated tigecycline MICs. Transposon mutagenesis generated nine mutants, the majority of which had either marA or acrB inactivated. Sequence analysis revealed a single nucleotide insertion in the open reading frame of the marR gene in less-susceptible strains of E. coli. CONCLUSIONS: This study suggested that a loss of MarR functionality due to a frameshift mutation resulted in constitutive overproduction of MarA and AcrAB and, consequently, in decreased susceptibility to tigecycline in clinical isolates of E. coli.
28
Genome-wide expression monitoring in Saccharomyces cerevisiae
Lisa Wodicka, Helin Dong, Michael Mittmann et al. · Nature Biotechnology · 1997 · 978 citations
Global Gene Expression in <i>Staphylococcus aureus</i> Biofilms
Karen E. Beenken, Paul M. Dunman, Fionnuala McAleese et al. · Journal of Bacteriology · 2004 · 578 citations · Full text